Skip to main content

Related news

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

Related professionals

Angel Manuel Lorente Cobo

Angel Manuel Lorente Cobo

Auxiliar Tècnic/a Recerca
Experimental Surgery Unit (ESU)
Preclinical Core Facilities
External Strategy Directorate
Read more
Emili Vallve Alcón

Emili Vallve Alcón

Predoctoral researcher
Basic, Translational and Clinical Pharmacy Research
Read more
Manuel Armengol Carrasco

Manuel Armengol Carrasco

Head of group
General Surgery
Read more
Josep Castellví Vives

Josep Castellví Vives

Translational Molecular Pathology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.